II
AURA icon

Inspire Investing’s Aura Biosciences AURA Stock Holding History

Inspire Investing’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36 Buy
5
+1
+25% +$6 ﹤0.01% 1081
2025
Q4 		$23 Buy
+4
New +$24 ﹤0.01% 1098

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Inspire Investing's AURA Position: Q1 2026 in Review

Inspire Investing increased its Aura Biosciences (AURA) stake by 25% in Q1 2026, buying an estimated $6 and bringing the position to 5 shares worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

Inspire Investing first reported a position in AURA in Q4 2025 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Inspire Investing held 5 shares of Aura Biosciences worth $36 as of Q1 2026.
  • Inspire Investing bought 1 Aura Biosciences share in Q1 2026, an estimated $6.
  • Aura Biosciences made up ﹤0.01% of Inspire Investing's portfolio in Q1 2026, its #1081 holding.
  • Inspire Investing first reported a position in Aura Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.